Aandelen in “Productie van analytische laboratoriuminstrumenten”

Aandeel Datum Koers Evolutie
vlag EyePoint Pharmaceuticals Inc 17/05 11,840 USD
-5,43% 		-5,43%

Nieuws over “Productie van analytische laboratoriuminstrumenten”

15/05 · Illumina To Webcast Upcoming Investor Conference · Persbericht

15/05 · Illumina To Webcast Upcoming Investor Conference · Persbericht

15/05 · Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases · Persbericht

15/05 · Aethlon Medical Announces Pricing of $4.7 Million Public Offering · Persbericht

13/05 · Waters Corporation to Present at the Jefferies 2024 Healthcare Conference · Persbericht

13/05 · ObeEnd - Pioneering Drug-Free Weight Management Wristband · Persbericht

10/05 · Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma · Persbericht

9/05 · PacBio Announces First Quarter 2024 Financial Results · Persbericht

8/05 · Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results · Persbericht

8/05 · Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument · Persbericht

7/05 · Waters Corporation (NYSE: WAT) Reports First Quarter 2024 Financial Results · Persbericht

7/05 · Mee met de markt: “Rentehoop is lentehoop” · Bolero.be

Europa stond er gisteren alleen voor om richting te zoeken. Japan hield de deuren dicht en ook de beurzen in het VK openden niet, waardoor de vrijdagse rentedaling (in de nasleep van zwakker dan verwacht Amerikaans banenrapport...

7/05 · Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL · Persbericht

3/05 · Illumina To Webcast Upcoming Investor Conference · Persbericht

3/05 · Avantor® to Participate in BofA Securities 2024 Health Care Conference · Persbericht

2/05 · Illumina Reports Financial Results for First Quarter of Fiscal Year 2024 · Persbericht

2/05 · Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results. · Persbericht

26/04 · Avantor® Reports First Quarter 2024 Results · Persbericht

22/04 · Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns · Persbericht

16/04 · PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance · Persbericht

12/04 · Illumina's planned divestment of GRAIL approved by the European Commission · Persbericht

Mijn selecties